FIELD: medicine, pharmaceutical technology.
SUBSTANCE: invention relates to a method for preparing medicinal suspension aerosol compositions based on hydrofluoroalkanes comprising parmitic and stearic acid calcium, magnesium and zinc salts additionally as solid agents improving stability of suspension, mechanical effect of a dosing valve, dosing precision and chemical stability of active substance.
EFFECT: improved and valuable properties of compositions.
8 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL AEROSOL COMPOSITION | 2009 |
|
RU2565438C2 |
PHARMACEUTICAL AEROSOL FORMULATIONS OF FORMOTEROL AND BECLOMETASONE DIPROPIONATE | 2010 |
|
RU2650175C2 |
AEROSOL MEDICINAL COMPOSITION FOR INHALATION (VARIANTS) | 1992 |
|
RU2098082C1 |
PHARMACEUTICAL COMPOSITIONS | 2011 |
|
RU2568882C2 |
TROVENTOL-BASED COMPOSITION | 2006 |
|
RU2457832C2 |
CRYSTALLINE LEVOSALBUTAMOL SULFATE, METHOD OF ITS OBTAINING AND PHARMACEUTICAL COMPOSITION, WHICH CONTAINS IT | 2005 |
|
RU2440972C2 |
METHOD FOR PREPARING METERED DOSE SPRAYED INHALER FOR TREATING RESPIRATORY DISEASE | 2012 |
|
RU2582218C2 |
DRY INHALATION POWDER | 1999 |
|
RU2221552C2 |
PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2642624C2 |
COMPOSITIONS INCLUDING FORMOTEROL AND FLUCTICASON PROPIONATE INDICATED FOR TREATING ASTHMA | 2000 |
|
RU2249454C2 |
Authors
Dates
2007-03-10—Published
2002-03-11—Filed